: In recent years, research has focused on colorectal cancer to implement modern treatment approaches to improve patient survival. In this new era, γδ T cells constitute a new and promising candidate to treat many types of cancer because of their potent killing activity and their ability to recognize tumor antigens independently of HLA molecules. Here, we focus on the roles that γδ T cells play in antitumor immunity, especially in colorectal cancer. Furthermore, we provide an overview of small-scale clinical trials in patients with colorectal cancer employing either in vivo activation or adoptive transfer of ex vivo expanded γδ T cells and suggest possible combinatorial approaches to treat colon cancer
Colorectal cancer is the third most common cancer worldwide with nearly 2 million cases per year. Im...
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US. The combinat...
Increasing evidence suggests that intestinal microbiota dysbiosis and chronic inflammation contribut...
\u3b3\u3b4 T cells are capable of recognizing tumor cells and exert potent cellular cytotoxicity aga...
Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is responsible ...
<div><p>Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is resp...
Colorectal cancer (CRC) is a global public health problem as it is the third most prevalent and the ...
Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is responsible ...
The recent successes of chimeric antigen receptor T cells in the treatment of hematological malignan...
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths in the developed world...
Colon cancer is still one of the leading causes of cancer death worldwide. Although the host immune ...
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US. For the vast...
This study designs a strategy for an adoptive cellular therapy (ACT) protocol based on the ex-vivo s...
© 2021 by the authors.Colorectal cancer (CRC) is a global public health problem as it is the third m...
Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is responsible ...
Colorectal cancer is the third most common cancer worldwide with nearly 2 million cases per year. Im...
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US. The combinat...
Increasing evidence suggests that intestinal microbiota dysbiosis and chronic inflammation contribut...
\u3b3\u3b4 T cells are capable of recognizing tumor cells and exert potent cellular cytotoxicity aga...
Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is responsible ...
<div><p>Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is resp...
Colorectal cancer (CRC) is a global public health problem as it is the third most prevalent and the ...
Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is responsible ...
The recent successes of chimeric antigen receptor T cells in the treatment of hematological malignan...
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths in the developed world...
Colon cancer is still one of the leading causes of cancer death worldwide. Although the host immune ...
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US. For the vast...
This study designs a strategy for an adoptive cellular therapy (ACT) protocol based on the ex-vivo s...
© 2021 by the authors.Colorectal cancer (CRC) is a global public health problem as it is the third m...
Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is responsible ...
Colorectal cancer is the third most common cancer worldwide with nearly 2 million cases per year. Im...
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US. The combinat...
Increasing evidence suggests that intestinal microbiota dysbiosis and chronic inflammation contribut...